« Previous
Next »
Fertility and Sterility
Volume 90, Issue 5
, Pages 2016.e1-2016.e5
, November 2008
Fatal colon cancer in a young egg donor: a physician mother's call for follow-up and research on the long-term risks of ovarian stimulation
References
- McKinley J. Premiere draws a crowd, and tears, for absent composer. New York Times, Arts Section, p. 1, August 11, 2003.
- Zeitz J. Executive Administrator SAR: personal communication, November 29, 2007.
- Nicoll E. American Society for Reproductive Medicine, personal communication, November 30, 2007.
- . Assessing the medical risks of human oocyte donation for stem cell research: workshop report. In: Giudice L, Santa E, Pool R editor. Washington, D.C.: National Academies Press; 2007;
- . Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thrombosis Thrombolysis. 2007;24:169–174
- Stolberg SG. The death of Jesse Gelsinger. New York Times, Health Section p. 2, November 28, 1999.
- . Cancer of the colon in an egg donor: policy repercussions for donor recruitment. Hum Reprod. 1998;13:227–231
- . Estimating the risk for ovarian syndrome (OHSS): implications for egg donation for research. Hum Fertil. 2007;10(3):183–187
- . Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2002;155:217–224
- Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005;161:607–615
- . Ovulation induction and cancer risk. Fertil Steril. 2005;83:261–274
- . Reproductive hormones and cancer: ovarian and colon cancer. Obstet Gynecol Clin N Am. 2002;29:527–540
- . Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 1996;56:4516–4521
- . Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab. 1999;84:2080–2085
- Burkman RT. Personal communication, November 29, 2007.
- . Long-term effects of ovulation-stimulating drugs on cancer risk. RBM Online. 2007;15:38–44
- . Health effects of egg donation may take decades to emerge. Nature. 2006;442:607–608
- . Financial incentives in recruitment of oocyte donors. Fertil Steril. 2000;74:216–220
- Society for Assisted Reproductive Technology. Available at https://www.sartcorsonline.com/rptCSR_PubliMultYear.aspx?ClinicPKID=0, accessed November 29, 2007.
- . Egg harvesting for stem cell research: medical risks and ethical problems. Reprod BioMed Online. 2006;13:573–579
- Parisian S. Open letter, 2005. Available at http://www.genetics-and-society.org/resources/items/200502_letter_parisian.html/, accessed July 14, 2007.
- Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;November 20
- Centers for Disease Control. 2004 Assisted reproductive technology report. Available at http://www.cdc.gov/ART/ART2004/nation.htm/. Accessed August 25, 2007.
- Physician's Desk Reference. Lupron injection. Montvale, N.J.: Thomson PDR; 2007;3259–71
- American Society of Reproductive Medicine. ASRM Ethics Committee report: financial compensation of oocyte donors 2007;88:305–9.
- . Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online. 2007;15:149–155
- . IVF, IVM, natural cycle IVF, minimal stimulation IVF—time for a rethink. Reprod Med Online. 2007;15:106–119
J. S. has nothing to disclose.
Dr. Schneider reports being the mother of an egg donor who subsequently died at age 31 of colon cancer.
PII: S0015-0282(07)04383-X
doi: 10.1016/j.fertnstert.2007.12.074
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 90, Issue 5
, Pages 2016.e1-2016.e5
, November 2008

